Clinical trial
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep…
NCT00277394 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00277394 |
|---|---|
| Title | Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis |
| Official title | Safety Profile of Innohep Versus Subcutaneous Unfractionated Heparin in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | innohep®, Heparin |
| Enrollment | 541 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jan 16, 2006 |
| Last update posted | Mar 6, 2025 |
| Countries | Bulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: